RAYDERM HYDRATING TONER (GLYCERIN TONER) LIQUID [VORY MEDICAL. INC]

RAYDERM HYDRATING TONER (GLYCERIN TONER) LIQUID [VORY MEDICAL. INC]
PDF | XML

NDC 72543-004-01
Set ID abc43916-710b-4e18-ada2-fa15cf68f28e
Category HUMAN OTC DRUG LABEL
Packager VORY MEDICAL. Inc
Generic Name
Product Class
Product Number
Application Number
  • ACTIVE INGREDIENT

    Glycerin (2.5%) - Skin Protectact

  • INACTIVE INGREDIENT

    Purified Water, Propanediol, Dipropylene, Methyl Gluceth-20, Glycereth-26, Glycerin, Pentylene Glycol, Betaine, C12-14 Pareth-12, Trehalose, Salvia Hispanica Seed Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Polyquaternium-51, Sodium Citrate, Sea Buckthorn Water, Butylene Glycol, Ethylhexylglycerin, 1,2-Hexanediol, Citric Acid, Sodium Palmitoyl Proline, Nymphaea Tetragona Flower Extract, Green tea Extract, Black Rice Bran Extract, Cucumber Extract, Caprylyl Glycol, Fragrance

  • PURPOSE

    Skin Protectact

  • WARNINGS

    Precautions of Use
    1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
    2) Refrain from using on wound sites.
    3) Storage and handling precautions:
    i) Keep out of reach of children.
    ii) Keep away from direct sunlight

  • KEEP OUT OF REACH OF CHILDREN

  • INDICATIONS & USAGE

    Apply the toner on the skin and spread evenly.

  • DOSAGE & ADMINISTRATION

    Apply the toner on the skin and spread evenly.

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    image description

  • INGREDIENTS AND APPEARANCE
    RAYDERM HYDRATING TONER 
    glycerin toner liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72543-004
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) glycerin6.25 g  in 250 mL
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    DIPROPYLENE GLYCOL (UNII: E107L85C40)  
    METHYL GLUCETH-20 (UNII: J3QD0LD11P)  
    GLYCERETH-26 (UNII: NNE56F2N14)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    BETAINE (UNII: 3SCV180C9W)  
    C12-14 PARETH-12 (UNII: M0LJS773XW)  
    TREHALOSE (UNII: B8WCK70T7I)  
    SALVIA HISPANICA SEED (UNII: NU0OLX06F8)  
    CENTELLA ASIATICA (UNII: 7M867G6T1U)  
    POLYQUATERNIUM-51 (2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE/N-BUTYL METHACRYLATE; 3:7) (UNII: EL9825H96J)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO)  
    NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72543-004-01250 mL in 1 PACKAGE; Type 0: Not a Combination Product10/11/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/11/2018
    Labeler - VORY MEDICAL. Inc (694721104)
    Registrant - VORY MEDICAL. Inc (694721104)
    Establishment
    NameAddressID/FEIBusiness Operations
    VORY MEDICAL. Inc694721104manufacture(72543-004)

Related Drugs